- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| STENOCARE Aktie jetzt für 0€ handeln | |||||
| Mo | Stenocare A/S: Germany's DKK 8.5 billion medical cannabis market in continued uncertainty over the new reimbursement rules | 236 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOWith this market update, STENOCARE A/S aims to provide its current understanding of the latest developments in the German medical... ► Artikel lesen | |
| 20.08. | Stenocare A/S: STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter | 149 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 30.06.2026. The report, which has not been... ► Artikel lesen | |
| 07.08. | Stenocare A/S: France reaches important milestone towards permanent legalisation of medical cannabis | 155 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (STENOCARE) provides an update on the regulatory development of the French medical cannabis programme. The long-awaited... ► Artikel lesen | |
| 03.07. | Stenocare A/S: STENOCARE completes integration of CannGros ApS | 198 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") is pleased to announce that the integration of CannGros ApS, acquired in November 2025, has now been... ► Artikel lesen | |
| 07.05. | Stenocare A/S Q1 Loss Decreases | 1 | RTTNews | ||
| 07.05. | Stenocare A/S: Interim report first quarter 2026 | 317 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which has not been reviewed... ► Artikel lesen | |
| 29.04. | Stenocare A/S: Communiqué from Annual General Meeting | 193 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARET, DENMARK
TICKER: STENO
On 29 April 2026 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at Lund Elmer Sandager Law... ► Artikel lesen | |
| 07.04. | Notice to Annual General Meeting in STENOCARE A/S | 1 | Cision News | ||
| 26.03. | STENOCARE A/S publishes Annual Report 2025 | 2 | Cision News | ||
| 26.02. | Stenocare A/S: Interim report fourth quarter and Financial Statement Release 2025 | 195 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 31.12.2025. The report, which has not been... ► Artikel lesen | |
| 11.02. | Stenocare A/S: STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership | 221 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") has entered a strategic partnership with Institut des Cannabinoïdes Médicaux Français (="ICMF") to... ► Artikel lesen | |
| 27.01. | Stenocare A/S: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany | 502 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
Stenocare Enters Strategic Partnership with WEECO Pharma GmbH to Launch Premium Medical Cannabis Oils in Germany. The first new... ► Artikel lesen | |
| 17.11.25 | Stenocare A/S: STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal | 262 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen | |
| 22.10.25 | Stenocare A/S: Interim report third quarter 2025 | 240 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 30.09.2025. The report, which has not been... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,168 | -1,68 % | Aurora Cannabis Inc.: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business | EDMONTON, AB, Sept. 9, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a biopharmaceutical... ► Artikel lesen | |
| ABBVIE | 221,30 | -0,23 % | Eli Lilly, AbbVie und Johnson & Johnson: Wie der Fünf-Milliarden-Dollar-Pharma-Run auf Psychedelika Emyria in den Fokus rückt | ||
| CANOPY GROWTH | 0,800 | +0,53 % | Canopy Growth Corp (2): Canopy Growth adds formats, formulations in Australia | ||
| TILRAY BRANDS | 3,485 | +0,58 % | Tilray Brands, Inc.: BrewDog steigt mit einer fünfjährigen Partnerschaft mit den Leicester Tigers in den Rugby-Sport ein und bringt Punk-Energie in die Welford Road | ELLON, Schottland und LONDON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BrewDog, ein führender Anbieter von Craft-Bier im Vereinigten Königreich und eine der weltweit bekanntesten Craft-Bier-Marken, hat... ► Artikel lesen | |
| INNOCAN PHARMA | 1,240 | -0,80 % | Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units | HERZLIYA, Israel and CALGARY, Alberta, Sept. 9, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that... ► Artikel lesen | |
| DERMAPHARM | 37,400 | -2,35 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| CRONOS GROUP | 2,678 | 0,00 % | Cronos Group Inc. - 8-K, Current Report | ||
| SYNBIOTIC | 1,000 | -1,77 % | Original-Research: SYNBIOTIC SE (von NuWays AG): Under review | Original-Research: SYNBIOTIC SE - from NuWays AG
24.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | -11,11 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,894 | -0,78 % | Organigram Global Inc.: Organigram Global treibt die Integration der Sanity Group unter einer einheitlichen globalen Betriebsstruktur voran | Führung, operatives Geschäft und Marktentwicklung werden über eine globale Plattform aufeinander abgestimmt, die Kanada mit Deutschland und anderen wichtigen internationalen Märkten verbindet
Die... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,420 | +4,05 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,139 | -1,13 % | SNDL Inc. - 6-K, Report of foreign issuer | ||
| CRESCO LABS | 0,621 | -0,16 % | Cresco Labs Acquires Nine Pennsylvania Dispensaries For $50 Million | ||
| NOVERIS HEALTH SCIENCES | 0,085 | +7,59 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,968 | +1,44 % | XFRA 0K91: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILQUANTUM BIOPHARMA... ► Artikel lesen |
Das Unternehmen STENOCARE A/S kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,26 % bei einem Aktienkurs von 0,113 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STENOCARE A/S finden Sie auf Wallstreet Online.